Nobivac® Pi
Canine parainfluenza virus is a cause of respiratory infection. It may cause disease in its own right or is association with other respiratory pathogens to cause more severe signs. Puppies and senior dogs with concurrent health issues may be at greatest risk. Note that Nobivac KC provides an alternative approach which provides protection agains two significant infectious triggers for respiratory disease in dogs. The disease is highly infectious and transmitted readily by aerosols (coughing or sneezing). Nobivac Pi is most often used as an annual booster vaccine for Nobivac DHPPi interim years when immunity to distemper, hepatitis and parvovirus (DHP) is not needed.
Presentation
Off-white or cream-coloured lyophilisate and clear colourless solvent for suspension for injection. Reconstituted product: off-pink or pink suspension.
Active ingredients
1 dose of 1 ml contains:
Live attenuated canine parainfluenza virus (CPi) strain Cornell: ≥ 5.5 log10 and ≤ 7.3 log10 TCID50*
*TCID50= Median Tissue Culture Infective Dose
Target species
Dog
Indications for use
For active immunisation of dogs from the age of 8 weeks onwards to reduce clinical signs of canine para-influenza infection and to reduce viral shedding.
Onset of immunity: 4 weeks after vaccination.
Duration of immunity: has not been demonstrated, but an anamnestic response is produced in dogs given a revaccination one year after basic vaccination.
Annual booster vaccination is recommended, particularly for those dogs at high risk (indoor or outdoor socialites, those housed in kennels or boarding establishments, etc).
Packaging
APET-plastic tray containing 10 or 50 vials
Legal category
POM-V
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018
